However, many patients with T2D experience initial success with anti-hyperglycemic drugs, only to become resistant to monotherapy over time, thus necessitating either an ancillary anti-diabetic agent or a transition to insulin in order to restore acceptable glycemic control. Here, INS is linked to type 2 diabetes mellitus.